Interestingly, we observed loss of BAP1 expression in the nucleus and in cytosol of meningioma cells as well as in BCC cells from two different germline BAP1 PV carriers belonging to two different families, confirming that meningioma and BCC are also included in the broader BAP1-TPDS spectrum [7,49,50]. This evidence concerns the gene BAP1 and skin basal cell carcinoma.